Skip to main content
Screener/Healthcare/Biotechnology

CTMX — CytomX Therapeutics, Inc.

NASDAQ
$3.31-0.03 (-0.75%)
Small CapPenny StockUnder $5HealthcareHigh Beta
$1.72
$8.21
$3.27
$3.37
EPS (TTM)$-0.36
P/E Ratio476.70
Dividend Yield—
Market Cap$591.8M
Volume194K
Prev Close$3.33
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$10.3M-$18.2M$-0.100.0%-177.9%
Q4 '25$663K-$26.5M$-0.1723.1%-3998.5%
Q3 '25$6.0M-$14.2M$-0.09100.0%-238.6%
Q2 '25$18.7M-$154K$-0.00100.0%-0.8%
Q1 '25$50.9M$23.5M$0.27100.0%46.2%
Q4 '24$38.1M$18.9M$0.24100.0%49.6%
Q3 '24$33.4M$5.7M$0.07100.0%17.2%
Q2 '24$25.1M-$6.5M$-0.08100.0%-26.0%
Get Your Daily Market Recap